Skip to Content

Sweet Spots

Pathogen-specific sugars may be the key to diagnosing disease.

Doctors commonly diagnose infectious diseases by checking patients’ blood for evidence of proteins or genes unique to different bacteria and viruses. Soon, they may be able to look instead for pathogen-specific sugars, thanks to a glass chip developed by biologist Denong Wang at Columbia University’s Genome Center. The technology could ultimately be less cumbersome than DNA-based tests and more accurate than protein-based tests for certain pathogens, allowing physicians to quickly screen for thousands of different infectious diseases at once using a small sample of blood.

When a person is exposed to a bacterium or virus, his or her body produces antibodies that bind to specific sugar molecules on the pathogen’s surface. Wang dotted glass chips with some of those same sugars, from bacteria such as Pneumococcus or Haemophilus influenza. He then washed blood samples over the chips; if people had been exposed to Pneumococcus, for example, antibodies from their blood stuck to the corresponding sugars on the chips and were then detected through a microscope.

One of the biggest challenges in making sugar chips has been getting the sugars to stick to glass. Wang discovered a relatively simple method: he coated the chip surface with nitrocellulose, which holds the sugars in place. Each of Wang’s first chips contains just 48 different sugars, but, he says, “We could spot up to 20,000 different sugars on a single chip, which would allow us to target all the most common pathogens.” Wang’s goal, in fact, is to create a diagnostic tool that could detect pathogens such as HIV, anthrax and smallpox. He is in discussion with a number of drug companies about commercializing his technology.

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.